DiaMedica Therapeutics Inc. (DMAC) has 47 open-market insider trades by 18 insiders since 2018. The most active filer is Randall Michael Giuffre, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Jan Stahlberg | 10% Owner | — | 3 | $23.0M | 2025-08-27 |
| Thomas von Koch | 10% Owner | — | 2 | $20.6M | 2025-07-23 |
| Ab Trill | 10% Owner | — | 1 | $15.3M | 2025-11-25 |
| Private Ab TomEqt | 10% Owner | — | 1 | $10.0M | 2023-06-23 |
| Private Ab TomEnterprise | 10% Owner | — | 1 | $3.0M | 2024-06-28 |
| Richard Jacinto II | 10% Owner | — | 1 | $1.4M | 2025-07-23 |
| David J. Wambeke | — | — | 3 | $1.1M | 2023-11-16 |
| Randall Michael Giuffre | Dir | — | 7 | $669K | 2026-01-02 |
| Ab TomEnterprise | 10% Owner | — | 1 | $553K | 2022-07-08 |
| Richard D. Pilnik | Dir | — | 7 | $550K | 2025-04-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Ab Trill | 10% Owner | Buy | $15.3M | 2025-11-17 |
| Jan Stahlberg | 10% Owner | Buy | $9.2M | 2025-08-13 |
| Thomas von Koch | 10% Owner | Buy | $10.0M | 2025-07-23 |
| Jan Stahlberg | 10% Owner | Buy | $10.8M | 2025-07-23 |
| Richard Jacinto II | 10% Owner | Buy | $1.4M | 2025-07-23 |
| Jan Stahlberg | 10% Owner | Buy | $3.0M | 2024-06-28 |
Companies that share insiders with DMAC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| David J. Wambeke | Chief Business Officer | Buy | $49K | 2023-11-16 |
| Private Ab TomEqt | 10% Owner | Buy | $10.0M | 2023-06-23 |
| Richard D. Pilnik | Director | Buy | $300K | 2023-06-23 |
| Randall Michael Giuffre | Director | Buy | $254K | 2023-06-23 |
| John Pauls Dietrich | President | Buy | $50K | 2023-06-23 |
| Scott Kellen | Secretary | Buy | $39K | 2023-06-23 |
| David J. Wambeke | — | Buy | $300K | 2023-06-23 |
| David J. Wambeke | — | Buy | $750K | 2023-04-10 |
| Randall Michael Giuffre | Director | Buy | $134K | 2022-12-08 |